Dietary Intervention Study for Hypertension (DISH)
NCT00000497 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL
Last updated 2015-04-15
Summary
The primary objective of this multicenter cooperative clinical trial was to determine if dietary modification would enable drug controlled hypertensive patients to remain at 'goal blood pressures' after antihypertensive medication was withdrawn. The proposal made use of the HDFP hypertensive population who had five years of treatment for their hypertension. Additionally, the group of investigators proposed to determine if dietary treatment would permit patients not previously adequately controlled under the HDFP program to achieve normalization of blood pressure with a combination of dietary modification and drug treatment. The study also proposed to search for predictors (i.e., levels of hormonal agents such as plasma renin activity) of responsiveness to dietary manipulation among the hypertensive population as well as to identify psychological attributes that might be of importance in managing these patients.
Conditions
- Cardiovascular Diseases
- Heart Diseases
- Hypertension
- Vascular Diseases
Interventions
- BEHAVIORAL
-
diet, sodium-restricted
- BEHAVIORAL
-
diet, reducing
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
collaborator NIH -
University of Mississippi Medical Center
lead OTHER
Principal Investigators
-
Herbert Langford · University of Mississippi Medical Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
Eligibility
- Min Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1980-01-31
- Completion
- 1994-09-30
More Related Trials
-
DASH Diet Intervention for Systemic Hypertension in Adolescents
NCT06616818 ·Status: WITHDRAWN ·Phase: NA
-
Dietary Patterns, Sodium Intake and Blood Pressure (DASH - Sodium)
NCT00000608 ·Status: COMPLETED ·Phase: PHASE2
-
Hypertension Prevention Trial (HPT) Feasibility Study
NCT00000501 ·Status: COMPLETED ·Phase: PHASE2
-
Mechanisms of Refractory Hypertension (High and Low Salt Diet)
NCT02357017 ·Status: WITHDRAWN ·Phase: NA
-
Weight Loss in Pre-Hypertensive Patients With Diastolic Dysfunction
NCT00911209 ·Status: TERMINATED ·Phase: NA
-
The Significance of Sodium Balance and the Value of Salt-blood Test in Identifying Salt Sensitive Patients
NCT05165823 ·Status: COMPLETED ·Phase: NA
-
Effects of the Dietary Approaches to Stop Hypertension(DASH) Sodium-restricted Diet in Diastolic Heart Failure
NCT00939640 ·Status: COMPLETED ·Phase: NA
-
Blood Pressure in Dialysis Patients
NCT01421771 ·Status: COMPLETED ·Phase: NA
-
Vascular Dysfunction in Hypertensive Postmenopausal Women
NCT03371823 ·Status: TERMINATED ·Phase: PHASE4
-
Adverse Neurogenic Actions of Dietary Salt
NCT02881515 ·Status: COMPLETED ·Phase: NA
-
When the Kidney Reacts to Nutritional Changes
NCT04142138 ·Status: COMPLETED ·Phase: NA
-
Potassium and Sodium to Control Blood Pressure in Hypertensives
NCT00000509 ·Status: COMPLETED ·Phase: PHASE3
-
Prevention of Hypertension: A Randomized Trial
NCT00000495 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Sodium Reduction on Blood Pressure and Physical Function in Older Adults
NCT04074941 ·Status: COMPLETED ·Phase: NA
-
Comparison on Blood Pressure Effect of an Equivalent Sodium Intake, With Different Nature, for Hypertensive Subjects
NCT05108402 ·Status: UNKNOWN ·Phase: NA
-
The Transition From Hypertension to Hypertensive Heart Disease and Heart Failure, the PREFERS Hypertension Study
NCT04190420 ·Status: ENROLLING_BY_INVITATION
-
Salt Reduction on Blood Pressure and Cardiovascular Organ Damage
NCT00152074 ·Status: COMPLETED ·Phase: PHASE3
-
Examining the Individual Response to a Restricted Sodium Diet in Hypertensive Patients
NCT04764253 ·Status: COMPLETED ·Phase: NA
-
Effects of Salt Intake on the Nervous Systems of Patients With Salt-Sensitive High Blood Pressure
NCT00001176 ·Status: COMPLETED
-
Nijmegen Antihypertensive Management Improvement Study
NCT00457483 ·Status: COMPLETED ·Phase: PHASE4
-
Potassium Intake-response Trial to Control Hypertension
NCT05758142 ·Status: TERMINATED ·Phase: NA
-
Potassium-Magnesium Citrate as a Blood Pressure Lowering Agent in Hypertensive Patients
NCT01074918 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Default BP Medication Intensification
NCT01994408 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Sodium Lowering Vascular Effects Trial
NCT05388032 ·Status: RECRUITING ·Phase: NA
-
Salt-Sensitivity and Immunity Cell Activation
NCT03753204 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2